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ABSTRACT  22 
 23 
The gut-brain axis is a bidirectional communication system between the central nervous system 24 
and the gastrointestinal tract, in which serotonin (5-HT) functions as a key neurotransmitter. 25 
Recent research has increasingly concentrated on tryptophan, the precursor to 5-HT and on the 26 
microbial regulation of tryptophan metabolism, with an emphasis on host-microbe control over 27 
kynurenine pathway metabolism and microbial-specific pathways that generate bioactive 28 
tryptophan metabolites. Here, we critically assess recent progress made towards a mechanistic 29 
understanding of the microbial regulation of tryptophan metabolism and microbiota-gut-brain 30 
axis homeostasis highlighting the role tryptophan metabolism plays in preclinical and clinical 31 
neuroscience and in the challenge to improve our understanding of how perturbed tryptophan 32 
metabolism contributes to stress-related psychiatric disorders. 33 
 34 
Abbreviations: 35 
5-HT: 5-hydroxytryptamine (serotonin) 36 
5-HTP: 5-hydroxytryptophan  37 
AAD: Aromatic amino Acid Decarboxylase 38 
AANAT: Arylalkylamine N-acetyltransferase 39 
AHR: Aryl Hydrocarbon receptor 40 
ASD: Autism Spectrum Disorder 41 
ASMT: Acetyl-Serotonin O-Methyltransferase 42 
CA: Cholic Acid 43 
CNS: Central Nervous System 44 
DCA: Deoxycholic Acid 45 
EC cells: Enterochromaffin cells  46 
ENS: Enteric Nervous System 47 
GF: Germ-Free 48 
GI tract: Gastrointestinal tract 49 
GPCR: G-Protein-Coupled Receptor 50 
IBD: Inflammatory Bowel Disease 51 
IBS: Irritable Bowel Syndrome 52 
IDO: Indoleamine dioxygenase 53 
KAT: Kynurenine aminotransferase 54 
KYNA: Kynurenic Acid  55 
L-KYN: L-Kynurenine 56 
MDD: Major Depressive Disorder 57 
QUIN: Quinolinic Acid  58 
SCFA: Short Chain Fatty Acid  59 
SERT: Serotonin Transporter 60 
SPF: Specific Pathogen-Free 61 
SSRI: Selective Serotonin Reuptake Inhibitors 62 
TDC: Tryptophan Decarboxylase 63 
TDO: Tryptophan 2,3-dioxygenase  64 
TnaA: Tryptophanase  65 








Host-microbe interactions are now more routinely considered in the context of brain function 72 
and behavior. Establishing the mechanistic basis for this fascinating dialogue between the gut 73 
microbiome and the gut-brain axis has proved more challenging. As the field transitions beyond 74 
compositional assessments of the gut microbiome, tryptophan has come under increasing 75 
scrutiny as a pivotal essential amino acid in the lexicon of host-microbial crosstalk. Recent 76 
advances in this field continue to demarcate the indirect means through which our gut microbes 77 
influence host metabolic pathways [1,2]. Direct microbial metabolism of tryptophan also yields 78 
microbial metabolites and candidate interkingdom signaling molecules acting as an interface 79 
between the host and its resident microorganisms with important physiological implications 80 
both in the gut and the brain [3,4]. Support continues to accumulate from studies of a broad 81 
swathe of gut-brain axis disorders that the metabolism of tryptophan is perturbed and associated 82 
with alterations in the composition or function of the gut microbiome [2]. In this review, we 83 
critically evaluate the recent advances in this area as we strive towards a mechanistic 84 
understanding of the microbial regulation of gut-brain axis homeostasis and the implications 85 
for neuroscience. 86 
 87 
TRYPTOPHAN METABOLISM 88 
 89 
Tryptophan metabolites have a huge impact both in the central nervous system (CNS) and in 90 
the periphery (see fig 1). Once absorbed from the gut they become available in the circulation 91 
for distribution to target sites both peripherally and in the CNS. Tryptophan can also be 92 
metabolized directly by the gut microbiota and generate a range of indoles with diverse 93 
biological activity [5]. The combination of microbial and host gastrointestinal metabolism of 94 
tryptophan is thus likely an important factor in the systemic availability of tryptophan, as well 95 
as indoles, kynurenine and serotonin (5-HT) produced locally [3]. Much work has been done 96 
to better understand the impact of aberrant host tryptophan metabolism in psychiatric disorders 97 
and to identify the extent to which these molecular mechanisms dictate the impact of the gut 98 
microbiota on host physiology, brain function and behavior.  99 
 100 
-- Insert Figure 1 here -- 101 
 102 
TRYPTOPHAN METABOLISM & GUT-BRAIN AXIS DISORDERS 103 
 104 
The importance of 5-HT in the gastrointestinal tract is consistent with the fact that ~95% of 5-105 
HT is produced endogenously by enterochromaffin cells in the gut where it is involved in 106 
functions such as motility and secretion. Disruption in central and peripheral serotonergic 107 
signaling pathways are reported in GI disorders, such as inflammatory bowel disease (IBD) [6] 108 
and irritable bowel syndrome (IBS) – a functional gastrointestinal disorder with significant 109 
psychiatric comorbidity - and in pathologies like autism spectrum disorder (ASD), a central 110 
nervous system disorder with comorbid gastrointestinal symptoms. For instance, activation of 111 
the kynurenine pathway has been reported in patients with IBD compared to controls. A sex-112 
difference in tryptophan metabolism has been observed in both controls and patients with IBD 113 
characterised by lower serum tryptophan levels in female compared to males. The authors 114 
suggested this sex-difference could have important implications for understanding the increased 115 
female prevalence for some inflammatory phenotypes [7]. Differences in microbial 116 
subnetworks have been demonstrated in IBS patients compared to controls with respect to 117 
functional connectivity of brain regions in the somatosensory network and GI sensorimotor 118 
function, pointing to alterations in interactions within the brain-gut-microbiome axis [8]. The 119 
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authors also pointed out the importance of members of the order Clostridiales in modulating 120 
host 5-HT biosynthesis and release. A recent study working with BTBR mice – a mouse-based 121 
model of ASD-like behaviors – exhibited microbiota-related impairments in 5-HT production 122 
in the intestine [9]. ASD is frequently associated with GI symptoms that can plausibly be linked 123 
to  dysregulation of tryptophan metabolism in the gut [11,12]. In a study of children with autism, 124 
the authors demonstrated elevated concentrations in urine of xanthurenic acid and quinolinic 125 
acid suggesting preferential transformation from tryptophan at the expense of kynurenic acid 126 
[12]. 127 
  128 
THE GUT MICROBIOME, STRESS RELATED PSYCHIATRIC DISORDERS AND 129 
TRYPTOPHAN METABOLISM 130 
  131 
An increasing number of studies report the impact of the intestinal microbiota on the fate and 132 
metabolism of tryptophan (see fig 2). Importantly, the immuno- and stress- sensitive enzymes 133 
responsible for the initial conversion of L-tryptophan to L-kynurenine – indoleamine-2,3- 134 
deoxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO) – may also be regulated directly or 135 
indirectly by the gut microbiome. Indeed, experiments have revealed that germ-free (GF) mice 136 
(i.e. mice devoid of microrganisms, raised in a sterile environment) have reductions in 137 
kynurenine pathway metabolism that could be restored by colonization post-weaning [13]. 138 
Although the precise mechanisms are unclear, there are several potential routes through which 139 
the intestinal microbiota could regulate the expression and activity of kynurenine pathway 140 
enzymes. Examples include the production of hydrogen peroxide, microbial priming of the host 141 
immune system, activation of the aryl hydrocarbon receptor, the secretion of microbial 142 
metabolites influencing gut barrier integrity or via TLRs (see also figure 3) [14]. Intestinal 143 
microbes are thought to be involved in stress-related disorders as exemplified by the study of 144 
Valles-Colomer et al. [15*] where differences in gut microbial composition were associated 145 
with lower quality of life (QoL) and depression status compared to healthy controls. In fact, 146 
certain strains of bacteria in the gut are able to directly utilize tryptophan consequently changing 147 
its availability to the host [16**,18]. Kelly et al. [18*] performed fecal microbiota transplants 148 
from depressed patients to rats depleted of intestinal microbiota and demonstrated that the 149 
depressive phenotype is transmitted via the transfer of the intestinal microbiota as is the 150 
physiological hallmark of depression in terms of increased tryptophan metabolism along the 151 
kynurenine pathway.  152 
 153 
-- Insert Figure 2 here -- 154 
 155 
TRYPTOPHAN & SEROTONIN 156 
 157 
Early studies in this field helped establish the principle that the gut microbiome regulated 158 
tryptophan availability and onward metabolism into 5-HT, not just locally in the gut but also in 159 
the CNS [14,20,20*]. Acute tryptophan depletion (ATD) leads to increased depressive-like 160 
behavior and a stronger reduction of tryptophan, 5-HT and 5-hydroxyindoleacetic acid in the 161 
medial prefrontal cortex and hippocampus of GF than in SPF mice [21*]. Interestingly, 162 
following ATD, GF mice behave more similarly to SPF mice under basal conditions. The 163 
authors concluded that the serotonergic system of GF mice, which is abnormal at baseline, is 164 
more vulnerable to ATD. Administration of prebiotics (i.e. substrates that are selectively 165 
utilized by, and promotes the growth and/or activity of, beneficial host microorganisms 166 
compared to probiotics, which are live microorganisms consumed to produce a health benefit) 167 
in mice has shown antidepressant and anti-anxiolytic effects which underlines the possibility of 168 
exerting beneficial effects on the serotonergic system by therapeutic targeting of the gut 169 
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microbiome, an appealing strategy, and one that can be expedited with an enhanced knowledge 170 
of the mechanisms underpinning this important emerging aspect of host-microbe dialogue [22]. 171 
 172 
Since 5-HT is mainly synthesized in the gut, it is not surprising that the intestinal microbiota 173 
can have a significant impact on its availability. Kwon et al. [23] demonstrated a considerable 174 
difference in the composition of the intestinal microbiota depending on whether or not the TPH-175 
1 gene –  the rate-limiting enzyme of 5-HT synthesis – was knocked out and whether the 176 
progenitors were heterozygous or homozygous for this gene. They also provided evidence that 177 
5-HT directly modulated the growth of commensal bacteria in vitro in a concentration-178 
dependent and species-specific manner. It has also been demonstrated that mice with a TPH2 179 
gene mutation, which leads to lower 5-HT biosynthesis in both enteric and CNS serotonergic 180 
neurons specifically, exhibit both brain and intestinal dysfunction and a slow release 5-HTP 181 
formulation was able to restore ENS-mediated GI function [24**].  182 
 183 
Another proposed mechanism [16**] is by microbial biotransformation of cholic acid (CA) - 184 
secreted by the liver – into deoxycholic acid (DCA). Raising luminal concentrations of DCA in 185 
the colon of GF mice to levels seen in specific-pathogen free (SPF) mice sufficiently increases 186 
colon and serum 5-HT compared to vehicle-injected controls. This restoration of peripheral 5-187 
HT correlates with elevations in colonic TPH1 expression. Sun et al. [25] further showed that 188 
the elevation of 5-HT seen in high fat diet rats can be restored to a conventional-like level by 189 
use of fecal microbiota transplantation from control animals which may imply that elevated 190 
levels of DCA and CA could lead to the upregulation of TPH1 expression in the small intestine. 191 
 192 
By colonization of previously GF mice with a complex microbiota,  De Vadder et al. [26*] 193 
demonstrated that the gut microbiota stimulates neuronal and mucosal 5-HT release and that 194 
maturation of the adult ENS in GF mice requires 5-HT4R–specific signaling. Moreover, the 195 
microbiota likely affects 5-HT3 receptor expression to modulate colonic secretion [27]. This 196 
study also addressed the importance of short-chain fatty acids (SCFAs:  microbial metabolites 197 
produced by bacterial fermentation of dietary fibers by the intestinal microbiota) in 5-HT 198 
colonic secretion and hypothesized that this effect could be mediated via acetate production by 199 
the gut microbiota. Another study confirmed this result in vitro by exposing BON cells (human 200 
EC cell model) to microbiota-derived SCFAs which significantly increased TPH1 mRNA 201 
expression [28]. There is thus growing evidence, including mechanistic insights, that the 202 
intestinal microbiota is a contributor to the colonic secretion of 5-HT. A very elegant study by 203 
Yano et al. [16**] introduced the concept that spore-forming bacteria could regulate host 5-HT 204 
synthesis in colonic enterochromaffin cells in mice. Indeed Mandić et al. [29] examined the 205 
specific involvement of the bacterium Clostridium Ramosum in colonic secretion of 5-HT in 206 
the gut and suggested it could be due to an induced expansion of enterochromaffin cells.  207 
 208 
5-HT availability - in both the brain and intestine - depends on 5-HT transporter (SERT) 209 
function. Recently Singhal et al.[30] emphasized differences in cecal and fecal microbiota 210 
composition of SERT-/- or SERT+/+ mice, concluding that SERT plays an important role in 211 
maintaining the homeostasis of the gut microbiota and that deficiency leads to loss of bacterial 212 
niches and altered microbial metabolic capabilities. In addition to being able to impact 5-HT 213 
production by acting on enterochromaffin cells, there are 5-HT-producing bacterial strains [14]. 214 
Lyte et al.[31] provided evidence that there could be a biogenic amine transport system in the 215 
biofilm of certain bacteria, particularly the genus Lactobacillus, demonstrating that bacteria are 216 
capable of modifying host availability of 5-HT. Since intestinal bacteria have an impact on 5-217 
HT availability, bacteria may be indirectly involved in psychiatric diseases. It is also of 218 
considerable interest whether or not intestinal bacteria are reciprocally affected by the use of 219 
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psychotropic drugs with serotonergic mechanisms of action. To address this question, Cussotto 220 
et al. [32] showed in vitro that two SSRI drugs, escitalopram and fluoxetine, modulate the 221 
growth of resident gut bacteria. The importance of these results were confirmed in a recent 222 
study which documented changes in microbial communities after chronic administration of 223 
fluoxetine [33]. 224 
 225 
One of the most understudied mechanisms by which the gut microbiota could influence the 226 
level of 5-HT in the gut lumen is deconjugation of 5-HT-O-glucuronide - produced by the liver 227 
- by β-glucuronidase, a bacterial enzyme. Ex-GF mice have the majority of 5-HT in an 228 
unconjugated form whereas GF mice have approximately 50% of the 5-HT in a conjugated 229 
form. This leads to the possibility that the intestinal microbiota could have a specific role in 230 
liberating biologically active free 5-HT [34]. Taken together, there is now evidence to postulate 231 
a role of microbiota in 5-HT production from EC cells and change in 5-HT availability in the 232 
host (see fig 3). 233 
 234 
-- Insert Figure 3 here -- 235 
  236 
TRYPTOPHAN & KYNURENINE 237 
 238 
The available recent evidence suggests that the gut microbiota can exert an impact on important 239 
kynurenine pathway enzymes at multiple levels of the gut-brain axis. By comparing GF, 240 
colonized GF and conventionally colonized animals, Moloney et al. [35] highlighted the role 241 
of the intestinal microbiota in modulating the expression of miRNAs associated with the 242 
kynurenine pathway in the mouse hippocampus. Evidence shows that the microbial 243 
composition of chronically stressed mice changes compared to controls in a way that is 244 
associated with the development of depression-like behavior. A Lactobacillus strain, possibly 245 
by the production of H2O2 [36], exerted a protective role against stress-induced depression-like 246 
behavior associated with inhibition of intestinal IDO1 activity and a decreased  circulating level 247 
of kynurenine. Another study focusing on kynurenine in MDD patients [37] supports those 248 
results as it showed that administration of Lactobacillus plantarum leads to a decrease in 249 
kynurenine concentrations and improved cognitive function. Kazemi et al. [38] also 250 
demonstrated the benefit of an 8-week probiotic treatment - Lactobacillus helveticus and 251 
Bifidobacterium longum supplementation - in MDD patients. This treatment resulted in a 252 
significant decrease in kynurenine/tryptophan ratio (used here as a marker of IDO activity) in 253 
serum samples compared to placebo. Furthermore, REGA3 has recently been identified [39] as 254 
an antimicrobial protein within the GI tract able to affect the composition of the gut microbiota 255 
towards an increase in Lactobacillus. Interestingly, REG3A-associated increases in 256 
Lactobacillus promotes production of kynurenine in gut epithelial cells in mice. By working 257 
with mice with an IDO-1 gene knockout in the context of obesity, Laurans et al.[40] found an 258 
increase of IL-22 target genes such as the antimicrobial proteins (Reg3g and Reg3b) in the 259 
intestine of High Fat Diet fed Ido1 -/- mice compared to high fat diet wild type mice 260 
highlighting that obesity may be associated with a microbiota-associated shift in tryptophan 261 
metabolism towards kynurenine production. Since the flow of kynurenine across the blood 262 
brain barrier is considered critical to its role in CNS pathology, harnessing the gut microbiota 263 
as a control point for kynurenine generation could have important therapeutic implications.  264 
  265 
TRYPTOPHAN & MELATONIN 266 
 267 
Melatonin is a hormone synthetized from 5-HT and mostly secreted by the pineal gland in 268 
mammals, but it can also act locally and be synthetized by several organs including the sites 269 
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within the gastrointestinal tract. Its best known role is the regulation of the circadian rhythm 270 
but has also been shown to affect multiple molecular pathways including immune function, 271 
apoptosis, proliferation, angiogenesis and oxidative stress [41]. Sleep deprivation is a common 272 
burden that must be considered seriously as it can impact the autonomic nervous system, 273 
endocrine system and immune function, and that can be a trigger factor of metabolic or mental 274 
diseases. Gao et al. [42] investigated the effect of melatonin in a mouse model of sleep 275 
deprivation and found melatonin mediated sleep-deprivation induced mucosal injury and 276 
altered gut microbiota composition. Intriguingly, they show that sleep deprivation negatively 277 
impacts the diversity and richness of colonic microbiota and that melatonin supplementation 278 
greatly improves this state. In the context of weaning stress, melatonin supplementation was 279 
able to improve body weight gain and intestinal morphology and to increase the richness indices 280 
of intestinal microbiota and shape the composition of intestinal microbiota in conventionally 281 
colonized mice [43]. However, in both antibiotic-treated and GF mice, melatonin failed to affect 282 
intestinal morphology suggesting that there could be an involvement of intestinal microbiota in 283 
the regulatory functions of melatonin in intestinal physiology. Interestingly, a third study [44] 284 
focused on lipid metabolism found that melatonin supplementation in high fat diet fed mice 285 
alleviated the lipid accumulation and was able to reverse gut microbiota dysbiosis. They also 286 
showed results that suggest that melatonin can act on the intestinal microbiota by increasing the 287 
number of acetic acid-producing strains. These recent studies suggest that melatonin acts on the 288 
intestinal microbiota in several very different contexts, which implies that its role is essential 289 
in many physiological conditions and that its impact should not to be neglected in future studies. 290 
 291 
TRYPTOPHAN & INDOLE 292 
 293 
Indole is produced from tryptophan via the enzyme tryptophanase by multiple indole-producing 294 
bacteria [45]. This metabolite plays a significant role for their survival and controls diverse 295 
physiological processes such as antimicrobial response, biofilm formation, motility and a range 296 
of other functions. Importantly, animal cells cannot synthesize indole. However, indole can be 297 
oxidized by non-indole-producing bacteria or eukaryotes into several biologically active 298 
derivatives [46]. Understanding how these tryptophan derivatives, synthesized by certain 299 
bacteria, can impact the host is an important research objective. There is growing evidence that 300 
these molecules have an impact at both peripheral and cerebral level, in particular through the 301 
binding to certain receptors such as the aryl hydrocarbon receptor (AHR)  [4,47], that promotes 302 
the expression of inflammation associated genes. Indole has been detected in the human gut at 303 
concentrations of 250-1100 µM [4] and indole derivatives synthetized by gut bacteria have been 304 
found in blood, peripheral tissues, urine and brain tissues which suggests an important role of 305 
those bacterial compounds. Some indole-derivatives are characterized by neurodepressive 306 
properties - namely oxindole and isatin - and excessive production of indole by the gut 307 
microbiota may adversely affect behavior in rats [47*]. 308 
 309 
An increasing number of studies are focusing on the activation of the AHR as it has shown to 310 
have profound effects upon immunological status of the GI tract. However, the range of ligands 311 
responsible for AHR-activation within the gut continues to expand [48]. Recently, indole and 312 
some of these derivatives have been shown to be potent activators or stimulators of AHR and 313 
thus to influence the transcription of important factors of the immune system. This discovery is 314 
potentially of major importance because it highlights activation of the host's immune system 315 
through metabolites produced by the intestinal microbiota. Koper et al.[49] studied the kinetics 316 
of tryptophan-derived AHR-ligands by using a Simulator of the Human Intestinal Microbial 317 
Ecosystem (SHIME) and were able to simulate the ascending, transverse and descending colon 318 
from fresh human fecal sample. Some kynurenine derivatives showed a constant concentration 319 
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through the colon, while other metabolites showed increased or decreased concentrations 320 
through different regions, although the implications of these region-specific variations are 321 
unclear. Table 1 lists some key indoles thought to activate the AHR and their potential 322 
physiological impact. 323 
 324 
TRYPTOPHAN & TRYPTAMINE 325 
 326 
Clostridium sporogenes and Ruminococcus gnavus are strains present in the gut microbiota 327 
capable of decarboxylating tryptophan to tryptamine through the specific enzyme tryptophan 328 
decarboxylase [50]. Tryptamine can play several roles in the gut such as signaling and has been 329 
shown to induce the release of 5-HT by enterochromaffin cells. Indeed, enteric neurons are able 330 
to take up tryptamine, which displaces 5-HT in intracellular synaptic vesicles, causing 5-HT 331 
release therefore might affect gastrointestinal motility[24**]. Bhattarai et al. [51**] uncovered 332 
a specific mechanism by which tryptamine-producing bacteria could accelerate gastrointestinal 333 
transit by activating the epithelial GPCR 5-HT4 receptor. To date, there are very few studies 334 
investigating the synthesis of tryptamine [50] by intestinal bacteria and the effect of this 335 
molecule in the body, but these promising initial studies indicate that there are some interesting 336 
discoveries to be made. 337 
 338 
CONCLUDING SECTION 339 
 340 
The essential role of tryptophan as a precursor to a range of bioactives important for signaling 341 
along the microbiome-gut-brain axis is increasingly appreciated in the context of psychological 342 
wellbeing and symptom generation. These tryptophan derivatives may facilitate both interorgan 343 
and interkingdom crosstalk and systemic availability of tryptophan, indoles, kynurenine, 5-HT 344 
and melatonin, each have an essential and unique aspect in maintaining signaling homeostasis 345 
along the microbiome-gut-brain axis. Microbial regulation of tryptophan availability and 346 
metabolism has important implications for many gut-brain axis disorders including GI disorders 347 
with psychiatric comorbidity, such as IBS, IBD and other CNS pathologies with GI dysfunction 348 
like ASD. These observations are likely missing pieces of the puzzle in understanding the origin 349 
and consequences of aberrant host tryptophan metabolism in many psychiatric disorders as 350 
well. Future research should look to clarify the importance of lifestyle choices such as diet, 351 
sleep, daily activity and exercise participation for tryptophan metabolism in health and disease. 352 
It remains to be seen if this fast accumulating information can be rationally integrated within a 353 
framework that enables mechanistically-oriented therapeutic targeting of the gut microbiome. 354 
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Figure Legends 660 
 661 
Figure 1: Tryptophan metabolism and the Microbiome-gut-brain axis 662 
 663 
An essential amino acid obtained from dietary proteins, tryptophan, serves as a precursor to a 664 
variety of imperative bioactive molecules, some generated by the host and some fabricated by 665 
gut microbes (indicated by blue arrows). The most widely known fate of tryptophan is 666 
conversion into 5-HT and melatonin downstream. Nevertheless, a large majority of tryptophan 667 
is metabolized along the kynurenine pathway giving rise to molecules often collectively 668 
referred to as “kynurenines”. The availability of tryptophan is also altered by gut microbes 669 
generating either indole and its derivatives, tryptamine or even 5-HT which can impact on 670 
gastrointestinal function via GPCR activation. An increasing number of studies highlight the 671 
importance of this pathway in metabolic and psychiatric disorders. 672 
 673 
Figure 2: Tryptophan metabolism pathways and stress related Gut / Brain Interactions 674 
 675 
Aberrant tryptophan metabolism can occur in response to stress and inflammation in both the 676 
gut and the brain. An imbalance in the concentration of the different molecules that these 677 
pathways generates has consequences upon gut-brain signaling.  In the gut, following immune 678 
activation or during the stress response, tryptophan is preferentially converted to kynurenine 679 
rather than 5-HT. Decreased 5-HT conversion from tryptophan – synthesized primarily by 680 
enterochromaffin cells - impacts on gastrointestinal motility and function. In the brain, 681 
tryptophan is metabolized along the kynurenine pathway by microglia and astrocytes leading 682 
to the formation of either kynurenic acid or quinolinic acid (by Astrocyte or Microglia, 683 
respectively). The majority of CNS kynurenine is derived from the periphery and once in the 684 
CNS, it can also participate in onwards metabolism. The balance between kynurenic acid and 685 
quinolinic acid is important for health and disease. Excessive activation of kynurenine 686 
metabolism may have neurotoxic consequences in clinical psychiatric and neurological 687 
disorders, such as depression. 688 
 689 
Figure 3: Candidate mechanisms for microbial regulation of tryptophan and serotonin 690 
release. 691 
 692 
The availability and metabolism of tryptophan is under the influence of various intrinsic and 693 
extrinsic factors. There are a number of potential mechanisms through which the gut 694 
microbiome can influence tryptophan metabolism and the production of 5-HT or other 695 
metabolites. 5-HT can be synthesized both in the brain and in the gut by two different rate-696 
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limiting isoenzymes of tryptophan hydroxylase (TPH) - TPH1 and TPH2, respectively. It has 697 
been shown recently that some bacteria found in the gut microbiota, in vitro, are able to 698 
synthesize 5-HT. The microbiota has several ways to modulate 5-HT availability by regulating 699 
5-HT secretion from enterochromaffin cells with short chain fatty acids (SCFA) increasing 700 
TPH1 mRNA expression. Microbial enzymes often biotransform metabolites produced by the 701 
liver, including the conversion of hepatic-derived cholic acid into deoxycholic acid leading to 702 
increased 5-HT in the colon and blood serum or by cleaving 5-HT-O-glucuronide, secreted into 703 
the gut lumen from the liver, into free 5-HT. 704 
 705 




Table 1. AHR ligands and their physiological impact on host metabolism 708 
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